BridgeBio Pharma, Inc. (BBIO) Shareholders’ equity 2019–2025
BridgeBio Pharma, Inc. (BBIO) shareholders’ equity at each fiscal year-end, per SEC filings.
-$2.1BFY2025 · since FY2019: $408.5M → -$2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.1B | -42.1% |
| FY2024 | -$1.5B | -8.4% |
| FY2023 | -$1.4B | -7.9% |
| FY2022 | -$1.3B | -44.1% |
| FY2021 | -$870.4M | -1603.1% |
| FY2020 | $57.9M | -85.8% |
| FY2019 | $408.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice